Retraction to: Acta Pharmacologica Sinica https://doi.org/10.1038/aps.2016.109, published online 12 December 2016
The Editor has retracted this article [1] because there is significant overlap of figures and text with [2].
Specifically:
-
Figure 1a [1] appears to be identical with sub panels in Figs. 1b and 1d [2]
-
Figure 1d [1] appears to be identical with a sub-panel in Fig. 1e [2]
-
Figures 2a and 2b [1] appears to be identical with Fig. 2a [2]
-
Figures 2c, 2d, 4a, 4b and 4c in [1] appear to be identical with Figs. 2c, 2d, 4a, 4b and 4c in [2]
-
Figure 3a [1] appears to be identical with Fig. 3b [2]
-
Figure 3b [1] appears to be identical with Fig. 3c [2]
-
Figures 5a, 5c, 5d and 5f in [1] appear to be identical with Figs. 6a, 6b, 6c and 6d in [2], respectively
-
Figure 6b [1] appears to be identical with Fig. 8a [2]
The Editor therefore has no confidence in this article.
The authors have told us that all the Western blots in this article were produced by an external experimental company; this was not stated in the article. [All authors agree with this retraction.]
References
Li JY, Huang WQ, Tu RH, Zhong GQ, Luo BB, He Y. Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt. Acta Pharmacol Sin. 2017;38:182–91.
Retracted article: Xu BC, Long HB, Luo KQ. Tert-butylhydroquinone lowers blood pressure in AngII-induced hypertension in mice via proteasome-PTEN-Akt-eNOS pathway. Sci Rep. 2016;6:29589.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1038/aps.2016.109.
About this article
Cite this article
Li, Jy., Huang, Wq., Tu, Rh. et al. Retraction Note: Resveratrol rescues hyperglycemia-induced endothelial dysfunction via activation of Akt. Acta Pharmacol Sin 41, 1262 (2020). https://doi.org/10.1038/s41401-020-0363-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41401-020-0363-0
